Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Mr. Aaron GreenCEO, President & Director | 36,65k | 21,01k | Acquisto | 0,57 | 1,45M | 2,60% |
| 2026-06-23 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 158,73k | 100,00k | Acquisto | 0,63 | 10,09M | 1,60% |
| 2026-06-16 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 172,41k | 100,00k | Acquisto | 0,58 | 9,93M | 1,77% |
| 2026-06-12 | Mr. Aaron GreenCEO, President & Director | 55,62k | 30,70k | Acquisto | 0,54 - 0,56 | 1,41M | 4,10% |
| 2026-06-12 | Dr. Thomas KosasaIndependent Director | 158,73k | 100,00k | Acquisto | 0,63 | 17,09M | 0,94% |
| 2026-05-18 | Dr. Thomas KosasaIndependent Director | 268,82k | 250,00k | Acquisto | 0,93 | 16,93M | 1,61% |
| 2026-04-23 | Dr. Thomas KosasaIndependent Director | 280,90k | 250,00k | Acquisto | 0,89 | 16,66M | 1,71% |
| 2026-02-06 | Dr. Thomas KosasaIndependent Director | 595,24k | 500,00k | Acquisto | 0,84 | 16,66M | 3,70% |
| 2026-04-01 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 903,61k | 750,00k | Acquisto | 0,83 | 9,76M | 10,20% |
| 2025-10-22 | Mr. Aaron GreenCEO, President & Director | -126,32k | 218,62k | Vendita | 1,20 - 2,23 | 659,10k | -16,08% |
| 2025-06-17 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 2,31M | 1,84M | Derivative Exercise and Retained Stock | 0,71 - 1,14 | 8,39M | 37,92% |
| 2023-12-08 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 372,56k | 281,66k | Acquisto | 0,48 - 1,41 | 8,39M | 4,65% |
| 2023-12-11 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 1,67M | 704,05k | Acquisto | 0,42 - 1,45 | 8,39M | 24,84% |
| 2025-05-09 | Dr. Jeffrey YuFounder, VP, Chief Medical Officer & Chairman | 5,95k | 0,00 | Open Market Derivative Acquisition | 11,50 | 5,95k | - |
| 2025-06-17 | Dr. Thomas KosasaIndependent Director | 5,48M | 4,20M | Derivative Exercise and Retained Stock | 0,71 - 1,14 | 15,74M | 53,43% |
| 2025-04-21 | Dr. Thomas KosasaIndependent Director | 683,40k | 543,88k | Acquisto | 0,38 - 0,86 | 15,74M | 4,54% |
| 2025-06-20 | Dr. Thomas KosasaIndependent Director | 1,20M | 505,60k | Acquisto | 0,42 - 0,93 | 15,74M | 8,23% |
| 2023-12-07 | Mr. Robert L. GoldenCFO, Corporate Secretary & Director | 300,00 | 513,00 | Acquisto | 1,71 | 169,57k | 0,18% |
| 2025-06-17 | Mr. Aaron GreenCEO, President & Director | 240,43k | 274,08k | Derivative Exercise and Retained Stock | 1,14 | 785,43k | 44,11% |
| 2024-02-16 | Mr. Eric CasaburiIndependent Director | 10,48k | 8,76k | Acquisto | 0,72 - 0,92 | 65,48k | 19,05% |
| 2025-10-15 | Mr. Eric CasaburiIndependent Director | 10,00k | 30,50k | Acquisto | 3,05 | 65,48k | 18,03% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
